For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
NPS activities for health professionalsNPS activities for health professionals
GPs, pharmacists, nurses and other health professionals can participate in our free educational and quality improvement activities including case studies, clinical audits and pharmacy practice reviews on various therapeutic topics. All our educational and quality improvement activities qualify for continuing professional development (CPD) points or qualify as an activity for the Quality Prescribing Initiative (QPI) of the Practice Incentives Program (PIP).
This list covers the current and most recent NPS activities. For more case studies go to the Case studies page, GPs can also review previous Clinical audits and pharmacists can review previous Pharmacy Practice Reviews.
Current/recent activities
tr>| Type | Title | Description | Dates |
|---|---|---|---|
| Case study |
Case study 72: Management of rhinosinusitis |
Jessica, a 26-year-old student, presents to you complaining of a 4 day history of coloured nasal discharge, headache, lethargy and sneezing. |
Complete and submit by: |
|
Pharmacy practice review
|
Reducing CVD risk: improving patient use of statins and/or ezetimibe (online activity) |
Provides pharmacists with the opportunity to review their episode of care with patients who are at risk of cardiovascular disease (CVD) and improve the adherence of patients to their lipid-modifying medicines. |
Now available |
| Case study |
Case study 71: Heart failure |
65-year-old Margaret visits her GP for a repeat prescription. She was diagnosed with heart failure 1 year ago (LVEF < 40%) after a myocardial infarction. |
Closed Report pending |
Clinical Audit |
Safe and effective use of antipsychotic therapy (Sample pack) |
Gives GPs an opportunity to assess and reinforce patient adherence to therapy, monitor for adverse effects of antipsychotic drugs, consider non-pharmacological approaches; and review ongoing need for antipsychotic drugs for behavioural and psychological symptoms of dementia. |
|
| Case study |
Case study 70: Antipsychotic therapy | Emily (28 years old) was diagnosed with schizophrenia 9 months ago. She was prescribed an antipsychotic (risperidone) and in the last 6 months her dose has been stable. |
Closed Report |
| Clinical Audit |
Reducing risk of osteoporotic fractures and falls (sample pack) |
Gives GPs an opportunity to assess patients who are at risk of osteoporosis. Building healthy bones and preventing fractures are key to management. Review 10 patients |
|
|
Clinical e-Audit
This software is designed for use on Microsoft Windows XP, Vista or Windows 7. |
CVD risk and lipid-modifying therapy |
Gives GPs an opportunity to assess absolute CVD risk, discuss risk with patients, consider prescribing lipid-modifying drugs for those at increased risk, and assess adherence.
|
Complete before 30 April 2012 to be recognised in the QPI year (1 May to 30 April) in which it is completed. |
|
Clinical e-Audit
This software is designed for use on Microsoft Windows XP, Vista or Windows 7. |
Management of hypertension |
Gives GPs an opportunity to assess absolute cardiovascular risk, modify risk factors, identify and aim for guideline-recommended blood pressure targets and tailor therapy according to coexisting conditions. |
Complete before 30 April 2012 to be recognised in the QPI year (1 May to 30 April) in which it is completed. |
|
Clinical e-Audit
This software is designed for use on Microsoft Windows XP, Vista or Windows 7. |
Review of proton pump inhibitor (PPI) prescribing | How are you managing the use of PPIs? |
Complete before 30 April to be recognised in the QPI year (1 May to 30 April) in which it is completed.
|
|
Clinical e-Audit
This software is designed for use on Microsoft Windows XP, Vista or Windows 7. |
Optimising management of type 2 diabetes |
How are you managing patients using antidiabetic agent(s) with a diagnosis of type 2 diabetes? |
Complete before 30 April to be recognised in the QPI year (1 May to 30 April) in which it is completed. |
| Kit - Health Professionals | Safe and appropriate use of generic medicines | Information to help ensure pharmacy assistants are competent to manage general questions about generic medicines | No closing date |
About points, incentives and QPI
Completing our activities can earn you continuing professional development (CPD) points from your professional association. General practices may also be eligible for financial incentives under the Quality Prescribing Initiative (QPI) of the Practice Incentives Program (PIP).
Date published: 2011-08-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
